Gene: ZBTB40
Official Full Name: zinc finger and BTB domain containing 40provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific. Involved in DNA damage response. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32508 | ZBTB40 Knockout cell line (HeLa) | Human | ZBTB40 | 1:3~1:6 | Negative | Online Inquiry |
KO32509 | ZBTB40 Knockout cell line (HCT 116) | Human | ZBTB40 | 1:2~1:4 | Negative | Online Inquiry |
KO32510 | ZBTB40 Knockout cell line (HEK293) | Human | ZBTB40 | 1:3~1:6 | Negative | Online Inquiry |
KO32511 | ZBTB40 Knockout cell line (A549) | Human | ZBTB40 | 1:3~1:4 | Negative | Online Inquiry |
ZBTB40 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to study the function of the ZBTB40 gene, a critical regulator of various biological processes, including cell proliferation and immune response. These knockout models utilize CRISPR/Cas9 technology to precisely disrupt the ZBTB40 gene, allowing researchers to investigate its role in gene expression, signaling pathways, and disease mechanisms.
The key functionality of these knockout cell lines is rooted in their ability to provide insights into the consequences of ZBTB40 gene disruption. By facilitating the examination of phenotypic changes, researchers can observe alterations in cellular morphology, growth rates, and response to external stimuli. This, in turn, helps uncover the gene’s involvement in pathological conditions such as cancer, autoimmunity, and other related disorders, making them indispensable tools in both basic and applied research settings.
In terms of scientific significance, ZBTB40 Gene Knockout Cell Lines are crucial for elucidating the gene's functional roles and its potential as a therapeutic target. The ability to model specific disease states opens up avenues for discovering novel intervention strategies in clinical research. Researchers can design experiments that assess the effects of pharmaceutical compounds on ZBTB40-deficient cells, accelerating drug development processes.
What sets these cell lines apart from alternatives is their high specificity and reproducibility. Unlike traditional methods that rely on pharmacological inhibition or RNA interference, knockout models offer a permanent alteration of the target gene, thereby providing more reliable data. Furthermore, our knockout cell lines come with thorough characterization, ensuring that researchers have confidence in the quality and integrity of the models they are working with.
By utilizing ZBTB40 Gene Knockout Cell Lines, researchers and clinicians can advance their understanding of ZBTB40-related pathways in health and disease, ultimately translating findings into better therapeutic outcomes. Our company prides itself on its commitment to providing high-quality biological products, backed by extensive expertise in genetic engineering and cell biology, ensuring that you have the tools necessary for groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.